PACIRA BIOSCIENCES, INC. Interest Expense
PACIRA BIOSCIENCES, INC. (PCRX) reported Interest Expense of $3.32 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-07
- PACIRA BIOSCIENCES, INC. interest expense for the quarter ending 2024-03-31 was $3.32M, a 65.42% decline year-over-year.
- PACIRA BIOSCIENCES, INC. interest expense for the quarter ending 2023-12-31 was $3.39M, a 69.31% decline year-over-year.
- PACIRA BIOSCIENCES, INC. interest expense for the quarter ending 2023-09-30 was $3.46M, a 64.85% decline year-over-year.
- PACIRA BIOSCIENCES, INC. interest expense for the quarter ending 2023-06-30 was $3.87M, a 56.24% decline year-over-year.
- PACIRA BIOSCIENCES, INC. interest expense for fiscal 2023 was $20.31M, a 49.20% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. interest expense for fiscal 2022 was $39.98M, a 25.91% increase from fiscal 2021.
- PACIRA BIOSCIENCES, INC. interest expense for fiscal 2021 was $31.75M, a 23.68% increase from fiscal 2020.
- PACIRA BIOSCIENCES, INC. interest expense for fiscal 2020 was $25.67M, a 8.65% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $3.32M 10-Q · filed 2024-05-07 | $6.70M derived: sum of 2 quarters · filed 2024-05-07 | $10.17M derived: sum of 3 quarters · filed 2024-05-07 | $14.03M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $6.85M derived: sum of 2 quarters · filed 2024-02-29 | $10.72M derived: sum of 3 quarters · filed 2024-02-29 | $20.31M 10-K · filed 2024-02-29 |
| 2023-09-30 | $3.46M 10-Q · filed 2023-11-02 | $7.33M derived: sum of 2 quarters · filed 2023-11-02 | $16.92M 10-Q · filed 2023-11-02 | $27.96M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $3.87M 10-Q · filed 2023-08-02 | $13.45M 10-Q · filed 2023-08-02 | $24.50M derived: sum of 3 quarters · filed 2024-05-07 | $34.35M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $9.59M 10-Q · filed 2024-05-07 | $20.63M derived: sum of 2 quarters · filed 2024-05-07 | $30.49M derived: sum of 3 quarters · filed 2024-05-07 | $39.32M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $20.90M derived: sum of 2 quarters · filed 2024-02-29 | $29.73M derived: sum of 3 quarters · filed 2024-02-29 | $39.98M 10-K · filed 2024-02-29 |
| 2022-09-30 | $9.86M 10-Q · filed 2023-11-02 | $18.69M derived: sum of 2 quarters · filed 2023-11-02 | $28.93M 10-Q · filed 2023-11-02 | $39.36M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $8.83M 10-Q · filed 2023-08-02 | $19.08M 10-Q · filed 2023-08-02 | $29.50M derived: sum of 3 quarters · filed 2024-02-29 | $36.84M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $10.25M 10-Q · filed 2023-05-03 | $20.67M derived: sum of 2 quarters · filed 2024-02-29 | $28.00M derived: sum of 3 quarters · filed 2024-02-29 | $35.02M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $17.76M derived: sum of 2 quarters · filed 2024-02-29 | $24.78M derived: sum of 3 quarters · filed 2024-02-29 | $31.75M 10-K · filed 2024-02-29 |
| 2021-09-30 | $7.33M 10-Q · filed 2022-11-03 | $14.36M derived: sum of 2 quarters · filed 2022-11-03 | $21.33M 10-Q · filed 2022-11-03 | $28.39M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $7.02M 10-Q · filed 2022-08-03 | $13.99M 10-Q · filed 2022-08-03 | $21.06M derived: sum of 3 quarters · filed 2023-02-28 | $28.19M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $6.97M 10-Q · filed 2022-05-04 | $14.03M derived: sum of 2 quarters · filed 2023-02-28 | $21.16M derived: sum of 3 quarters · filed 2023-02-28 | $26.62M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $14.19M derived: sum of 2 quarters · filed 2023-02-28 | $19.65M derived: sum of 3 quarters · filed 2023-02-28 | $25.67M 10-K · filed 2023-02-28 |
| 2020-09-30 | $7.13M 10-Q · filed 2021-11-03 | $12.59M derived: sum of 2 quarters · filed 2021-11-03 | $18.61M 10-Q · filed 2021-11-03 | $24.61M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $5.46M 10-Q · filed 2021-08-03 | $11.48M 10-Q · filed 2021-08-03 | $17.48M derived: sum of 3 quarters · filed 2022-02-28 | $23.41M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $6.02M 10-Q · filed 2021-05-04 | $12.02M derived: sum of 2 quarters · filed 2022-02-28 | $17.96M derived: sum of 3 quarters · filed 2022-02-28 | $23.84M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $11.94M derived: sum of 2 quarters · filed 2022-02-28 | $17.82M derived: sum of 3 quarters · filed 2022-02-28 | $23.63M 10-K · filed 2022-02-28 |
| 2019-09-30 | $5.94M 10-Q · filed 2020-10-30 | $11.82M derived: sum of 2 quarters · filed 2020-10-30 | $17.63M 10-Q · filed 2020-10-30 | $23.39M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $5.88M 10-Q · filed 2020-08-06 | $11.69M 10-Q · filed 2020-08-06 | $17.45M derived: sum of 3 quarters · filed 2021-03-01 | $23.09M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $5.81M 10-Q · filed 2020-05-07 | $11.57M derived: sum of 2 quarters · filed 2021-03-01 | $17.21M derived: sum of 3 quarters · filed 2021-03-01 | $22.61M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $11.40M derived: sum of 2 quarters · filed 2021-03-01 | $16.79M derived: sum of 3 quarters · filed 2021-03-01 | $21.95M 10-K · filed 2021-03-01 |
| 2018-09-30 | $5.64M 10-Q · filed 2019-11-08 | $11.04M derived: sum of 2 quarters · filed 2019-11-08 | $16.20M 10-Q · filed 2019-11-08 | $21.30M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $5.40M 10-Q · filed 2019-08-08 | $10.55M 10-Q · filed 2019-08-08 | $15.66M derived: sum of 3 quarters · filed 2020-02-21 | $20.79M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $5.16M 10-Q · filed 2019-05-02 | $10.26M derived: sum of 2 quarters · filed 2020-02-21 | $15.39M derived: sum of 3 quarters · filed 2020-02-21 | $20.61M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $10.23M derived: sum of 2 quarters · filed 2020-02-21 | $15.46M derived: sum of 3 quarters · filed 2020-02-21 | $18.05M 10-K · filed 2020-02-21 |
| 2017-09-30 | $5.13M 10-Q · filed 2018-11-01 | $10.35M derived: sum of 2 quarters · filed 2018-11-01 | $12.94M 10-Q · filed 2018-11-01 | $14.80M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $5.23M 10-Q · filed 2018-08-02 | $7.82M 10-Q · filed 2018-08-02 | $9.67M derived: sum of 3 quarters · filed 2019-02-28 | $11.27M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $2.59M 10-Q · filed 2018-05-03 | $4.45M derived: sum of 2 quarters · filed 2019-02-28 | $6.05M derived: sum of 3 quarters · filed 2019-02-28 | $7.78M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $3.46M derived: sum of 2 quarters · filed 2019-02-28 | $5.19M derived: sum of 3 quarters · filed 2019-02-28 | $7.06M 10-K · filed 2019-02-28 |
| 2016-09-30 | $1.60M 10-Q · filed 2017-11-08 | $3.33M derived: sum of 2 quarters · filed 2017-11-08 | $5.20M 10-Q · filed 2017-11-08 | $7.08M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $1.73M 10-Q · filed 2017-08-02 | $3.60M 10-Q · filed 2017-08-02 | $5.48M derived: sum of 3 quarters · filed 2018-02-28 | $7.39M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $1.87M 10-Q · filed 2017-05-04 | $3.75M derived: sum of 2 quarters · filed 2018-02-28 | $5.66M derived: sum of 3 quarters · filed 2018-02-28 | $7.60M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.79M derived: sum of 2 quarters · filed 2018-02-28 | $5.73M derived: sum of 3 quarters · filed 2018-02-28 | $7.72M 10-K · filed 2018-02-28 |
| 2015-09-30 | $1.91M 10-Q · filed 2016-11-02 | $3.85M derived: sum of 2 quarters · filed 2016-11-02 | $5.84M 10-Q · filed 2016-11-02 | $14.12M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.94M 10-Q · filed 2016-08-04 | $3.94M 10-Q · filed 2016-08-04 | $12.21M derived: sum of 3 quarters · filed 2017-03-01 | $14.25M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.00M 10-Q · filed 2016-05-02 | $10.27M derived: sum of 2 quarters · filed 2017-03-01 | $12.31M derived: sum of 3 quarters · filed 2017-03-01 | $14.39M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $8.28M 10-K · filed 2017-03-01 | $10.31M derived: sum of 2 quarters · filed 2017-03-01 | $12.39M derived: sum of 3 quarters · filed 2017-03-01 | $8.28M 10-K · filed 2016-02-25 |
| 2014-09-30 | $2.04M 10-Q · filed 2015-10-27 | $4.12M derived: sum of 2 quarters · filed 2015-10-27 | $6.22M 10-Q · filed 2015-10-27 | $8.15M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $2.08M 10-Q · filed 2015-07-30 | $4.18M 10-Q · filed 2015-07-30 | $6.11M derived: sum of 3 quarters · filed 2016-02-25 | $8.01M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $2.11M 10-Q · filed 2015-04-30 | $4.04M derived: sum of 2 quarters · filed 2016-02-25 | $5.93M derived: sum of 3 quarters · filed 2016-02-25 | $7.84M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $3.82M derived: sum of 2 quarters · filed 2016-02-25 | $5.73M derived: sum of 3 quarters · filed 2016-02-25 | $7.25M 10-K · filed 2016-02-25 |
| 2013-09-30 | $1.89M 10-Q · filed 2014-10-30 | $3.81M derived: sum of 2 quarters · filed 2014-10-30 | $5.33M 10-Q · filed 2014-10-30 | $5.67M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $1.91M 10-Q · filed 2014-07-31 | $3.43M 10-Q · filed 2014-07-31 | $3.78M derived: sum of 3 quarters · filed 2015-02-24 | $4.23M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $1.52M 10-Q · filed 2014-05-01 | $1.86M derived: sum of 2 quarters · filed 2015-02-24 | $2.32M derived: sum of 3 quarters · filed 2015-02-24 | $2.81M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $799.00K derived: sum of 2 quarters · filed 2015-02-24 | $1.29M derived: sum of 3 quarters · filed 2015-02-24 | $1.81M 10-K · filed 2015-02-24 |
| 2012-09-30 | $456.00K 10-Q · filed 2013-10-31 | $950.00K derived: sum of 2 quarters · filed 2013-10-31 | $1.46M 10-Q · filed 2013-10-31 | $2.18M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $494.00K 10-Q · filed 2013-08-06 | $1.01M 10-Q · filed 2013-08-06 | $1.72M derived: sum of 3 quarters · filed 2014-02-25 | $2.63M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $514.00K 10-Q · filed 2013-05-08 | $1.23M derived: sum of 2 quarters · filed 2014-02-25 | $2.14M derived: sum of 3 quarters · filed 2014-02-25 | $2.81M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $712.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.62M derived: sum of 2 quarters · filed 2014-02-25 | $2.30M derived: sum of 3 quarters · filed 2014-02-25 | $4.78M 10-K · filed 2014-02-25 |
| 2011-09-30 | $910.00K 10-Q · filed 2012-11-01 | $1.59M derived: sum of 2 quarters · filed 2012-11-01 | $4.07M 10-Q · filed 2012-11-01 | $5.45M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | $676.00K 10-Q · filed 2012-08-09 | $3.16M 10-Q · filed 2012-08-09 | $4.54M derived: sum of 3 quarters · filed 2013-03-07 | $5.62M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $2.48M 10-Q · filed 2012-05-09 | $3.86M derived: sum of 2 quarters · filed 2013-03-07 | $4.94M derived: sum of 3 quarters · filed 2013-03-07 | $5.83M derived: sum of 4 quarters · filed 2013-03-07 |
| 2010-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $2.46M derived: sum of 2 quarters · filed 2013-03-07 | $3.35M derived: sum of 3 quarters · filed 2013-03-07 | $3.96M 10-K · filed 2013-03-07 |
| 2010-09-30 | $1.08M 10-Q · filed 2011-10-31 | $1.96M derived: sum of 2 quarters · filed 2011-10-31 | $2.58M 10-Q · filed 2011-10-31 | |
| 2010-06-30 | $887.00K 10-Q · filed 2011-08-11 | $1.50M 10-Q · filed 2011-08-11 | ||
| 2009-12-31 | $1.72M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |